Literature DB >> 6269765

The role of lipid peroxidation in CCl4-induced damage to liver microsomal enzymes: comparative studies in vitro using microsomes and isolated liver cells.

G Poli, K Cheeseman, T F Slater, M U Dianzani.   

Abstract

The question as to whether CCl4 decreases the activities of glucose-6-phosphatase and cytochrome P-450 in liver endoplasmic reticulum mainly through its action in stimulating lipid peroxidation has been investigated using Promethazine to block lipid peroxidation. The investigation, moreover, has compared the effects of CCl4, with and without Promethazine, on isolated rat hepatocytes with corresponding effects on rat liver microsomal suspensions. Our data give no support for the view that products of lipid peroxidation are the main cause of the decrease in cytochrome P-450 observed in CCl4-intoxication. However, our present results are consistent with lipid peroxidation being a major contributory factor to the decrease in glucose-6-phosphatase activity observed in CCl4-induced liver injury.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6269765     DOI: 10.1016/0009-2797(81)90162-9

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  12 in total

1.  Interactions between calvatic acid and related compounds with rat liver microsomes.

Authors:  A Miglietta; E Gadoni; M Buffa; A Olivero; L Gabriel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Oct-Dec       Impact factor: 2.441

2.  Studies on lipid peroxidation in normal and tumour tissues. The Novikoff rat liver tumour.

Authors:  K H Cheeseman; M Collins; K Proudfoot; T F Slater; G W Burton; A C Webb; K U Ingold
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

3.  Assessing inflammatory liver injury in an acute CCl4 model using dynamic 3D metabolic imaging of hyperpolarized [1-(13)C]pyruvate.

Authors:  Sonal Josan; Kelvin Billingsley; Juan Orduna; Jae Mo Park; Richard Luong; Liqing Yu; Ralph Hurd; Adolf Pfefferbaum; Daniel Spielman; Dirk Mayer
Journal:  NMR Biomed       Date:  2015-10-16       Impact factor: 4.044

4.  Effects of Schisandrin B and alpha-tocopherol on lipid peroxidation, in vitro and in vivo.

Authors:  D H Mak; S P Ip; P C Li; M K Poon; K M Ko
Journal:  Mol Cell Biochem       Date:  1996-12-20       Impact factor: 3.396

5.  Promethazine inhibits the formation of aldehydic products of lipid peroxidation but not covalent binding resulting from the exposure of rat liver fractions to CCl4.

Authors:  G Poli; K H Cheeseman; F Biasi; E Chiarpotto; M U Dianzani; H Esterbauer; T F Slater
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

6.  Constitutive and inducible profile of glutathione S-transferase subunits in biliary epithelial cells and hepatocytes isolated from rat liver.

Authors:  M Parola; M E Biocca; G Leonarduzzi; E Albano; M U Dianzani; K S Gilmore; D J Meyer; B Ketterer; T F Slater; K H Cheeseman
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

7.  Biochemical changes in isolated hepatocytes exposed to tert-butyl hydroperoxide. Implications for its cytotoxicity.

Authors:  P Buc-Calderon; I Latour; M Roberfroid
Journal:  Cell Biol Toxicol       Date:  1991-04       Impact factor: 6.691

8.  Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions.

Authors:  G Poli; M U Dianzani; K H Cheeseman; T F Slater; J Lang; H Esterbauer
Journal:  Biochem J       Date:  1985-04-15       Impact factor: 3.857

9.  Biochemical mechanism of irreversible cell injury caused by free radical-initiated reactions.

Authors:  A Bhatnagar
Journal:  Mol Cell Biochem       Date:  1994-08-17       Impact factor: 3.396

10.  Studies on lipid peroxidation in normal and tumour tissues. The Yoshida rat liver tumour.

Authors:  K H Cheeseman; S Emery; S P Maddix; T F Slater; G W Burton; K U Ingold
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.